152 related articles for article (PubMed ID: 11720755)
1. Surgical treatment of stage III non-small cell lung cancer.
Orlowski TM; Szczesny TJ
Lung Cancer; 2001 Dec; 34 Suppl 2():S137-43. PubMed ID: 11720755
[TBL] [Abstract][Full Text] [Related]
2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
3. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
4. Extended surgical resection in stage III non-small cell lung cancer.
Hillinger S; Weder W
Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
[TBL] [Abstract][Full Text] [Related]
5. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R
Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
8. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
Eckardt J; Jakobsen E; Licht PB
Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
[TBL] [Abstract][Full Text] [Related]
9. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
12. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
13. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer.
Takizawa T; Terashima M; Koike T; Akamatsu H; Kurita Y; Yokoyama A
J Thorac Cardiovasc Surg; 1997 Feb; 113(2):248-52. PubMed ID: 9040617
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
15. [Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer].
Marra A; Hillejan L; Pöttgen C; Zaboura G; Fechner S; Greschuchna D; Stamatis G
Pneumologie; 2002 Dec; 56(12):773-80. PubMed ID: 12486615
[TBL] [Abstract][Full Text] [Related]
16. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
17. Surgical approach to locally advanced non-small cell lung cancer.
Donington JS; Pass HI
Cancer J; 2013; 19(3):217-21. PubMed ID: 23708068
[TBL] [Abstract][Full Text] [Related]
18. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
[TBL] [Abstract][Full Text] [Related]
20. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]